Warner Chilcott Deal Promises 4x Return For Sponsors
Bain Capital LLC, Thomas H. Lee Partners and J.P. Morgan Chase Partners would hold shares in healthcare company Warner Chilcott plc valued at about $453 million following the proposed $8.5 billion acquisition of the drug firm by strategic buyer Actavis Inc, suggesting an investment multiple of nearly 4x over the life of the investment.
28 May 2013•2 mins read
